Healthcare fraud: A look back at a pivotal year

The word fraud framed by other words
From a healthcare fraud enforcement perspective, 2016 was nothing short of a dynamic year. (Getty/Devonyu)

From a healthcare fraud enforcement perspective, 2016 was nothing short of a dynamic year. 

It was punctuated by the arrival of several important trends within the addiction treatment, post-acute care and compound pharmaceutical industries.

It also featured a Supreme Court ruling on a False Claims Act legal theory, and a changing enforcement landscape in the aftermath of the Yates memo.

As 2016 comes to a close, let's look back at some of the fraud trends that emerged—or in some cases intensified—over the past 12 months.

Suggested Articles

Data and analytics company Health Catalyst reported its Q2 results the same week it announced some major deals.

Ballad Health saw its profits from the latest financial quarter decline by 22% due to volume declines from the COVID-19 pandemic and other expenses.

After eleven straight quarters of reporting positive earnings, Highmark’s AHN saw million in losses in the first half of the year due to COVID-19.